ABCB1/4 gallbladder cancer risk variants identified in India also show strong effects in Chileans.


Journal

Cancer epidemiology
ISSN: 1877-783X
Titre abrégé: Cancer Epidemiol
Pays: Netherlands
ID NLM: 101508793

Informations de publication

Date de publication:
04 2020
Historique:
received: 20 09 2019
revised: 08 11 2019
accepted: 15 11 2019
pubmed: 15 2 2020
medline: 17 9 2020
entrez: 15 2 2020
Statut: ppublish

Résumé

The first large-scale genome-wide association study of gallbladder cancer (GBC) recently identified and validated three susceptibility variants in the ABCB1 and ABCB4 genes for individuals of Indian descent. We investigated whether these variants were also associated with GBC risk in Chileans, who show the highest incidence of GBC worldwide, and in Europeans with a low GBC incidence. This population-based study analysed genotype data from retrospective Chilean case-control (255 cases, 2042 controls) and prospective European cohort (108 cases, 181 controls) samples consistently with the original publication. Our results confirmed the reported associations for Chileans with similar risk effects. Particularly strong associations (per-allele odds ratios close to 2) were observed for Chileans with high Native American (=Mapuche) ancestry. No associations were noticed for Europeans, but the statistical power was low. Taking full advantage of genetic and ethnic differences in GBC risk may improve the efficiency of current prevention programs.

Sections du résumé

BACKGROUND
The first large-scale genome-wide association study of gallbladder cancer (GBC) recently identified and validated three susceptibility variants in the ABCB1 and ABCB4 genes for individuals of Indian descent. We investigated whether these variants were also associated with GBC risk in Chileans, who show the highest incidence of GBC worldwide, and in Europeans with a low GBC incidence.
METHODS
This population-based study analysed genotype data from retrospective Chilean case-control (255 cases, 2042 controls) and prospective European cohort (108 cases, 181 controls) samples consistently with the original publication.
RESULTS
Our results confirmed the reported associations for Chileans with similar risk effects. Particularly strong associations (per-allele odds ratios close to 2) were observed for Chileans with high Native American (=Mapuche) ancestry. No associations were noticed for Europeans, but the statistical power was low.
CONCLUSION
Taking full advantage of genetic and ethnic differences in GBC risk may improve the efficiency of current prevention programs.

Identifiants

pubmed: 32058310
pii: S1877-7821(19)30153-5
doi: 10.1016/j.canep.2019.101643
pii:
doi:

Substances chimiques

ABCB1 protein, human 0
ATP Binding Cassette Transporter, Subfamily B 0
multidrug resistance protein 3 9EI49ZU76O

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

101643

Informations de copyright

Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest None.

Auteurs

Felix Boekstegers (F)

Statistical Genetics Group, Institute of Medical Biometry and Informatics, University of Heidelberg, Germany.

Katherine Marcelain (K)

Department of Basic and Clinical Oncology, Medical Faculty, University of Chile, Chile.

Carol Barahona Ponce (C)

Statistical Genetics Group, Institute of Medical Biometry and Informatics, University of Heidelberg, Germany; Department of Basic and Clinical Oncology, Medical Faculty, University of Chile, Chile.

Pablo F Baez Benavides (PF)

Department of Basic and Clinical Oncology, Medical Faculty, University of Chile, Chile.

Bettina Müller (B)

Servicio de Oncología Médica, Instituto Nacional del Cáncer, Santiago, Chile.

Gonzalo de Toro (G)

Servicio de Anatomía Patológica, Hospital de Puerto Montt, Puerto Montt, Chile.

Javier Retamales (J)

Servicio de Oncología Médica, Instituto Nacional del Cáncer, Santiago, Chile.

Olga Barajas (O)

Department of Basic and Clinical Oncology, Medical Faculty, University of Chile, Chile; Oncology, Hospital Clínico Universidad de Chile, Santiago, Chile.

Monica Ahumada (M)

Department of Basic and Clinical Oncology, Medical Faculty, University of Chile, Chile; Oncology, Hospital Clínico Universidad de Chile, Santiago, Chile.

Erik Morales (E)

Servicio de Anatomía Patológica, Hospital Regional, Talca, Chile.

Armando Rojas (A)

Biomedical Research Labs, Medicine Faculty, Catholic University of Maule, Talca, Chile.

Verónica Sanhueza (V)

Servicio de Anatomía Patológica, Hospital Padre Hurtado, Santiago, Chile.

Denisse Loader (D)

Servicio de Anatomía Patológica, Hospital Padre Hurtado, Santiago, Chile.

María Teresa Rivera (MT)

Servicio de Anatomía Patológica, Hospital del Salvador, Santiago, Chile.

Lorena Gutiérrez (L)

Servicio de Anatomía Patológica, Hospital San Juan de Dios, Santiago, Chile.

Giuliano Bernal (G)

Laboratory of Molecular and Cellular Biology of Cancer (CancerLab), Department of Biomedical Sciences, Faculty of Medicine, Universidad Católica del Norte, Coquimbo, Chile.

Alejandro Ortega (A)

Servicio de Anatomía Patológica, Hospital Regional, Arica, Chile.

Domingo Montalvo (D)

Department of Surgery, Hospital Juan Noe Crevani, Arica, Chile.

Sergio Portiño (S)

Oncology, Hospital Clínico Universidad de Chile, Santiago, Chile.

Maria Enriqueta Bertrán (ME)

Secretaría Regional Ministerial de Salud, Ministerio de Salud, Valdivia, Chile.

Fernando Gabler (F)

Servicio de Anatomía Patológica, Hospital San Borja Arriarán, Santiago, Chile.

Loreto Spencer (L)

Servicio de Anatomía Patológica, Hospital Regional Guillermo Grant Benavente, Concepción, Chile.

Jordi Olloquequi (J)

Laboratory of Cellular and Molecular Pathology, Instituto de Ciencias Biomédicas, Facultad de Ciencias de la Salud, Universidad Autónoma de Chile, Talca, Chile.

Rosa González Silos (R)

Statistical Genetics Group, Institute of Medical Biometry and Informatics, University of Heidelberg, Germany.

Christine Fischer (C)

Institute of Human Genetics, University of Heidelberg, Germany.

Dominique Scherer (D)

Statistical Genetics Group, Institute of Medical Biometry and Informatics, University of Heidelberg, Germany.

Mazda Jenab (M)

International Agency for Research on Cancer (IARC), World Health Organization, Lyon, France.

Krasimira Aleksandrova (K)

Nutrition, Immunity and Metabolism Senior Scientist Group, Department of Nutrition and Gerontology, German Institute of Human Nutrition Potsdam-Rehbruecke (DIfE), Nuthetal, Germany; University of Potsdam, Institute of Nutritional Science, Potsdam, Germany.

Verena Katzke (V)

Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Elisabete Weiderpass (E)

International Agency for Research on Cancer (IARC), World Health Organization, Lyon, France.

Tahereh Moradi (T)

Division of Epidemiology, Department of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.

Krista Fischer (K)

Estonian Genome Centre, Institute of Genomics, University of Tartu, Estonia.

Willem Bossers (W)

The Lifelines Cohort Study, Groningen, the Netherlands.

Hermann Brenner (H)

Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), German Cancer Consortium (DKTK), Heidelberg, Germany.

Kristian Hveem (K)

The Nord-Trøndelag Health (HUNT) Research Centre, Norwegian University of Science and Technology (NTNU), Trondheim, K.G. Jebsen Centre for Genetic Epidemiology, Department of Public Health and Nursing, NTNU, Norwegian University of Science and Technology, Norway.

Niina Eklund (N)

Genomics and biobank, National Institute for Health and Welfare (THL), Helsinki, Finland.

Uwe Völker (U)

Interfakultäres Institut für Genetik und Funktionelle Genomforschung, Universitätsmedizin Greifswald, Germany.

Melanie Waldenberger (M)

Research Unit of Molecular Epidemiology and Institute of Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany.

Macarena Fuentes Guajardo (M)

Instituto de Alta Investigación, Tarapacá University, Chile.

Rolando Gonzalez-Jose (R)

Instituto Patagónico de Ciencias Sociales y Humanas, Centro Nacional Patagónico, CONICET, Puerto Madryn, Argentina.

Gabriel Bedoya (G)

Facultad de Ciencias Exactas y Naturales, Universidad de Antioquia, Medellín, Colombia.

Maria C Bortolini (MC)

Instituto de Biociências, Universidad Federal do Rio Grande do Sul, Puerto Alegre, Brazil.

Samuel Canizales (S)

Facultad de Química, Universidad Nacional Autónoma de México, Ciudad de México, Mexico.

Carla Gallo (C)

Unidad de Neurobiología Molecular y Genética, Laboratorios de Investigación y Desarrollo, Facultad de Ciencias y Filosofía, Universidad Peruana Cayetano Heredia, Lima, Peru.

Andres Ruiz Linares (A)

Ministry of Education Key Laboratory of Contemporary Anthropology and Collaborative Innovation Center of Genetics and Development, School of Life Sciences and Human Phenome Institute, Fudan University, Shanghai 200433, China; Aix-Marseille Univ, CNRS, EFS, ADES, Marseille 13007, France.

Francisco Rothhammer (F)

Instituto de Alta Investigación, Tarapacá University, Chile.

Justo Lorenzo Bermejo (J)

Statistical Genetics Group, Institute of Medical Biometry and Informatics, University of Heidelberg, Germany. Electronic address: Lorenzo@imbi.uni-heidelberg.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH